| 8.60 Data as of May 17 |  +0.11 / +1.30%Today’s Change | 2.76 Today|||52-Week Range 10.68 | +117.17% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Other | MARKET CAP $61.3M |
Oramed Pharmaceuticals, Inc. Hi-Tech Park 2/5 Jerusalem -- 91390 |
| Individual stakeholders | 6.37% |
| Mutual fund holders | -- |
| Other institutional | -- |
| Nadav Kidron, MBA | President, Chief Executive Officer & Director |
| Yifat Zommer, MBA, CPA | Chief Financial Officer, Secretary & Treasurer |
| Ehud Arbit, MD | Director-Research & Development |
| Miriam Kidron, PhD | Director, Chief Medical & Technology Officer |
| Roy Eldor, MD | Head-Medical Affairs |
.
